newsfilter
← Latest News
GlobeNewswire·

23andMe Special Committee responds to CEO's take-private proposal

ME

SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the Board of Directors of 23andMe Holding Co. (NASDAQ:ME), a leading human genetics and biopharmaceutical company, today sent the